New York State Common Retirement Fund Beyond Spring Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.13 - $2.66 $12,655 - $29,792	-11,200 Reduced 98.39%	183 $0
Q4 2021 Feb 02, 2022	SELL	$4.02 - $16.84 $27,179 - $113,855	-6,761 Reduced 37.26%	11,383 $52,000
Q3 2021 Nov 02, 2021	BUY	$9.26 - $31.31 $64,708 - $218,794	6,988 Added 62.64%	18,144 $286,000
Q2 2021 Aug 02, 2021	BUY	$9.37 - $12.12 $1,461 - $1,890	156 Added 1.42%	11,156 $116,000
Q2 2019 Aug 09, 2019	BUY	$13.36 - $23.7 $146,960 - $260,700	11,000 New	11,000 $261,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.